Slice Of Healthcare

Our guest: Philip Kantoff, Co-Founder and CEO of Convergent Therapeutics, Inc.In this episode we discuss: Kantoff's background Overview of Convergent Therapeutics What are the current treatments of prostate cancer and why does it remain an unmet need? Radiation is a relatively well established approach for cancer therapies, but targeted radio-pharmaceuticals are emerging as an exciting new option. Can you tell us more about this new field? Status of your pipeline What's next? Our sponsors for this episode are Sage Growth Partners, GoodRX and Quantum HealthSage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media - @sagegrowthpartnersGoodRx is a company that operat